(600257)"DAHU HEALTH INDUSTRY CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 600257 · · 14 pages · Chinese
Summary by 6ix AI
The report confirms that the financial data presented is accurate and complete, with the board of directors taking legal responsibility for its contents. Key financial highlights include a decrease in revenue compared to the previous year, while total profit has shown a significant increase.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Dahu Health Industry Co., Ltd. on 6ix
Earlier from Dahu Health Industry
- Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Hunan Jurisdiction and Semi-annual Performance Briefing
- Semi-annual Report for 2026
- Announcement on Expected Profit in Semi-annual Performance for 2026
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Resolutions of the 26th Meeting of the 9th Board of Directors
Follow Dahu Health Industry into a list and get an email when it puts out news.
Follow Dahu Health Industry